SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Elixir network is a new primitive, purpose-built to power the next generation of institutional liquidity. Elixir powers deUSD – a fully collateralized, yield-bearing synthetic dollar.   Elixir is the most widely adopted network by RWAs: exclusively bringing funds from BlackRock, Hamilton Lane, and others to DeFi for the first time through deUSD. The Elixir network is secured by 30,000+ global validators.

Elixir

Elixir is seeing significant momentum and high social media visibility as traders characterize it as a holiday weekend runner. While many community members celebrate the rapid price appreciation, others are raising concerns regarding the depegging of associated stablecoin assets.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is currently trending as community members rally around its focus on cannabis culture and its potential for real-world integration in the industry, despite ongoing debate regarding its long-term value and price volatility. Supporters are actively engaging with marketing efforts and building long-term conviction, while skeptics continue to voice concerns about the lack of fundamental utility.

Bonfida is known as the top infrastructure developer on Solana. This accolade has been earned from their contributions to the ecosystem by providing services and products that allow for the wider ecosystem to flourish.  Their contributions to the ecosystem include creating a new Serum Core engine, the Asset Agnostic Orderbook (AOB), simplifying the way users transact on Solana, and the first perpetual swap on Solana, Audaces, to name a few. As a result of these, their developers are highly respected within the Solana ecosystem.

Bonfida

Bonfida is seeing a surge in community engagement and trading volume as investors draw comparisons to recent parabolic rallies in the Solana ecosystem. The discussion is heavily centered on technical chart patterns and speculation regarding a potential breakout, with many market participants actively debating whether to accumulate for long-term growth or trade the momentum.

Melania memes are digital collectibles intended to function as an expression of support for and engagement with the values embodied by the symbol MELANIA

Melania Trump

The MELANIA crypto token continues to face intense scrutiny and skepticism from the community, with many investors labeling it a pump-and-dump scheme associated with the Trump family. Discussion is heavily focused on the coin's dramatic value collapse, ongoing controversy surrounding its project utility, and community members expressing strong resentment over financial losses.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines is currently a top focus for biotech investors due to the ongoing speculation regarding a significant acquisition, with institutional analysts actively upgrading price targets based on the high strategic value of its multi-selective RAS(ON) inhibitor pipeline. The market is closely watching for potential deal news while balancing the company's valuation against its potential to transform oncology standards of care for RAS-mutant cancers.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors rally behind its vision of a decentralized, AI-native infrastructure for autonomous agents, bolstered by anticipation of strategic partnerships and token buyback programs. Community sentiment remains highly optimistic, with many focusing on the project's long-term utility and its potential to disrupt traditional centralized code repositories.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is gaining significant momentum as the community highlights high conviction and ongoing token supply locks as key indicators of long-term strength. Investors are actively discussing the project's brand development and upcoming anniversary, fueling a sentiment that the ecosystem is positioned for a breakout.

DEGEN is a reward token for Farcaster users, born from meme culture. It features a unique tipping system that allows the community to reward high-quality content creators. DEGEN also powers the Degen Chain, one of the pioneering Layer 3s launched on Base. Known as the “Las Vegas of blockchains,” it provides a platform for building and using Degen apps, offering a space for fun, innovation, and community-driven experiences.

Degen

DEGEN is gaining traction as community members emphasize the project's transition from a Farcaster tipping token into a brand with tangible utility, including token buybacks, burns, and upcoming platform launches. Investors are actively debating the potential for long-term growth versus the risks of volatility, with many monitoring the founder's social presence and upcoming ecosystem updates for signs of a sustained breakout.

Plume is the first RWAfi L1 network focused on crypto natives. We build infrastructure to make it easy to connect the real world and the crypto markets. We go against the traditional view of RWAs by changing its definition – it’s not just TradFi onchain but instead building net new crypto-first RWA use cases to the market including things like RWA derivatives/speculation, borrow/lend, yield farming, and more.  We are a permissionless EVM chain and ecosystem that is redefining and driving the RWA market forward. We do this through novel technologies that vertically integrate all the elements of RWAs into a single stack and ecosystem. Our tokenization engine, an EVM chain, compliance &amp; regulatory tooling, RWA data normalization, etc are all first class objects so that they work seamlessly together to make it easy to bring anything in the real world (assets, data, etc.) onchain.

Plume Network

Plume Network is trending as investors focus on its specialized RWA (Real-World Asset) infrastructure and recent institutional-grade integrations with firms like Apollo and Centrifuge. The community is actively discussing its potential for long-term growth, comparing its trajectory to other established RWA projects while closely watching for broader exchange listings and mainnet developments.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as investors highlight its massive user growth and the recent reduction in token inflation alongside its integration with AI-powered infrastructure. The community is actively discussing the protocol's role in the 'agentic economy' and cross-chain functionality, driving sentiment around its potential as a core utility asset.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.

A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Ava Bio's Cell-Based Platform Approach

A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a Premier Longevity Forum: Inside Ava Bio's Cell-Based Platform Approach A Unique Klotho-based Anti-Aging Therapy to Be Introduced at a...

Vertex to Participate in Upcoming May Investor Conferences

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced management participation in two upcoming investor conferences. Charlie Wagner, Chief Operating and Financial Officer, will...

VRTX's Alyftrek, Journavx & Casgevy See Strong Momentum in Q1 Earnings

Vertex's new drugs are gaining momentum as Alyftrek tops $1 billion in sales and Journavx prescriptions accelerate.

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Biotech Stocks To Add to Your Watchlist - May 6th

Danaher, Avalo Therapeutics, Vertex Pharmaceuticals, United Therapeutics, argenex, ImmunityBio, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological science and technology t...

Vertex Announces CASGEVY Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that a reimbursement agreement was signed with the GKV-Spitzenverband for its CRISPR/Cas9 gene-edited therapy, CASGEVY...

QRG Capital Management Inc. Increases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX

QRG Capital Management Inc. increased its stake in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 16.2% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 18,396 shares of the pharmaceutical company's stock after...

Principal Financial Group Inc. Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX

Principal Financial Group Inc. increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 2.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 415,100 s...

M&T Bank Corp Increases Holdings in Vertex Pharmaceuticals Incorporated $VRTX

M&T Bank Corp boosted its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX - Free Report) by 19.5% during the fourth quarter, according to the company in its most recent filing...

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

VRTX
Vertex Pharmaceuticals, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest VRTX News

VRTXVertex Pharmaceuticals, Inc.